• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

UArizona Health Sciences Researchers to Study Long COVID as Part of National Collaborative
This study of post-acute sequelae of SARS-CoV-2, which is aimed at understanding the reasons for persistence of symptoms and organ involvement, assumes tremendous importance for us to devise new treatments and cures to address the long-term consequences of this pandemic, " said Dr.Sairam Parthasarathy, one of the project ' s multiple principal investigators.In addition to Parthasarathy, who is a professor of medicine and chief of the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine at the UArizona College of Medicine – Tucson and a BIO5 Institute member, principal investigators include Dr.Marilyn Glassber...
Source: The University of Arizona: Health - December 16, 2021 Category: Universities & Medical Training Authors: mittank Source Type: research

Respiratory Tract Bacterial Extracts Could Prevent COVID-19
This study is unique because it is the first time researchers have targeted the receptor – the lock – with a bacterial extract and shown it protects against infection with live virus. We ' re essentially removing the lock from the cell wall so there ' s nothing for the virus ' key to attach to, " said senior author Dr.  Donata Vercelli, professor of  cellular and molecular medicine at the UArizona College of Medicine – Tucson and professor of genetics at the BIO5 Institute.  When SARS-CoV-2 enters the lungs, it binds to receptors including the angiotensin converting enzyme 2 receptor, known as ACE2, on the out...
Source: The University of Arizona: Health - December 14, 2021 Category: Universities & Medical Training Authors: mittank Source Type: research

UCLA-led research proposes strategies to control pandemic with fewer restrictions on the economy
An international team led by UCLA Fielding School of Public Health researchers has developed and tested two strategies for sustaining economic activity during the COVID-19 pandemic. If used together and followed closely, they write, the approaches could reduce transmission of the coronavirus by an amount comparable to that of a strict lockdown, while also maintaining economic activity.The team, made up of researchers from nine institutions and led byDr. Akihiro Nishi, a UCLA assistant professor of epidemiology, put forward two concepts that Nishi describes as rationing time and rationing capacity.“Although lockdown and s...
Source: UCLA Newsroom: Health Sciences - November 11, 2020 Category: Universities & Medical Training Source Type: news

Physician-Scientist Leads Program to Tackle COVID-19 Health Disparities in Arizona
Brittany Uhlorn Dr. Sairam Parthasarathy is one of 11 principal investigators for the National Institutes of Health Community Engagement Alliance Against COVID-19 Disparities. Monday BIO5 Institute201407064__DSC0561-web.JPG Dr. Sairam Parthasarathy, professor of medicine and chief of the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine in the UArizona College of Medicine – Tucson, was recently named one of 11 lead investigators for the National Institutes of Health Community Engagement Alliance Against COVID-19 Disparities.HealthBIO5College of Medicine - TucsonCOVID-19 Media contact(s)Brittany Uhlo...
Source: The University of Arizona: Health - October 30, 2020 Category: Universities & Medical Training Authors: mittank Source Type: research

Study Shows SARS-CoV-2 Antibodies Provide Lasting Immunity
Digital media& downloads Study Shows SARS-CoV-2 Antibodies Provide Lasting Immunity UArizona Heath Sciences researchers developed one of the most accurate COVID-19 antibody tests available and now have shown antibodies persist for months after infection, providing long-term immunity. Stacy Pigott Today University of Arizona Health SciencesPresident-Robbins_klh7008-2-web.jpg Staff process samples at blood draw at the UArizona Cole and Jeannie Davis Sports Center, which served as a temporary clinic for antibody testing of first responders and health care workers in late April. Kris Hanning/University of Arizona He...
Source: The University of Arizona: Health - October 13, 2020 Category: Universities & Medical Training Authors: spigott Source Type: research

UCLA draws record $1.4 billion in research funding
UCLA attracted record support for its wide-ranging research in the 2019 –20 fiscal year, receiving $1.427 billion in research funding.2020 is the third consecutive year that the university has topped its previous best. Research support has grown by 38% since 2015. UCLA now ranks sixth among all universities in total research expenditures.“This is a tribute to the great work being done across disciplines at UCLA,” said Roger Wakimoto, vice chancellor for research. “These funds help bring about major breakthroughs in medical science, advance knowledge in numerous other disciplines, strengthen our teaching, and suppor...
Source: UCLA Newsroom: Health Sciences - October 12, 2020 Category: Universities & Medical Training Source Type: news

UCLA is part of NIH-sponsored clinical trial for possible COVID-19 therapies
UCLA Health is one of 75 sites around the globe participating in a clinical trial sponsored by the National Institutes of Health to test the effectiveness of a candidate antiviral drug against COVID-19.The drug, called remdesivir, was originally developed as a treatment for Ebola. Although it was found to be safe, it was not effective in treating patients with the disease. In laboratory tests, however, it appears to work against the SARS-CoV-2 virus that  causes COVID-19, which has raised hope that it may be effective against the coronavirus that has swept the globe, sickening and killing thousands.The clinical trial wa...
Source: UCLA Newsroom: Health Sciences - April 3, 2020 Category: Universities & Medical Training Source Type: news

Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein
April 3, 2020—(BRONX, NY)—Montefiore Health System andAlbert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial. This treatment has the potential to help people who have serious lung complications as a result of COVID-19. Recruitment for the trial began in March and is still underway.
Source: Einstein News - April 3, 2020 Category: Universities & Medical Training Source Type: news

Study reveals how long COVID-19 remains infectious on cardboard, metal and plastic
The virus that causes COVID-19 remains for several hours to days on surfaces and in aerosols,a new study published in  the New England Journal of Medicine found.The study suggests that people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.“This virus is quite transmissible through relatively casual contact, making this pathogen very hard to contain,” said James Lloyd-Smith, a co-author of...
Source: UCLA Newsroom: Health Sciences - March 20, 2020 Category: Universities & Medical Training Source Type: news

First childhood flu helps explain why virus hits some people harder than others
Why are some people better able to fight off the flu than others? Part of the answer, according to a new study, is related to the first flu strain we encounter in childhood.Scientists from UCLA and the University of Arizona have found that people ’s ability to fight off the flu virus is determined not only by the subtypes of flu they have had throughout their lives, but also by the sequence in which they are been infected by the viruses. Their study is published in the open-access journal PLoS Pathogens.The research offers an explanation for why some people fare much worse than others when infected with the same strain...
Source: UCLA Newsroom: Health Sciences - February 4, 2020 Category: Universities & Medical Training Source Type: news